Published in Surgery Litigation and Law Weekly, June 26th, 2009
"Our objective is to provide such a description with a Kaplan-Meier survival analysis, which may enable accurate predictions of the probability of recurrent vertigo after a given time or number of injections. Injections of IT gentamicin were administered for unilateral definite Meniere's disease. One injection (or rarely more) in a 6-week period...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.